A.Bufe - Session1 - Ischemia and Viability - How to select the right patientEuro CTO Club
1) The document discusses strategies for selecting the right patients for recanalization of a chronic total occlusion (CTO), including evaluating ischemia, viability of myocardium, and prognostic factors.
2) It reviews evidence from studies on the outcomes of CTO recanalization in different patient groups, such as those with low ejection fraction.
3) The key factors discussed for selecting patients include evaluating ischemic burden through stress testing, assessing viability through cardiac MRI, and aiming for complete revascularization of still viable myocardium.
Chapter 6 - Introduction to 12 Lead Interpretationryanhall911
This document provides a summary of a training chapter on 12-lead electrocardiogram (ECG) interpretation for paramedics. It outlines objectives of being able to recognize ST-elevation myocardial infarction (STEMI) on a 12-lead ECG. It discusses identifying important ECG features and relating them to lead locations on the heart. It emphasizes localization of STEMI rather than full interpretation. The document provides guidance on criteria for identifying STEMI and practicing recognition in various lead locations on sample ECGs.
This document summarizes the results of a study on 23 patients, mostly male and with an average age of 32.87, who underwent surgery to repair shoulder injuries. The majority of patients were right-handed and injured their shoulders participating in sports, mostly recreational. Most patients showed general shoulder laxity. Patients were followed for an average of 6.8 months after surgery and showed improvements in shoulder function based on standard assessment scores including ASES, ROWE, OXFORD, and WALCH.
Implante de válvula transcateter. Inovare - Braile via femoral.Jose Carlos Dorsa
Aortic stenosis is the most common form of cardiovascular disease after hypertension and coronary artery disease. This document discusses transcatheter aortic valve replacement (TAVR) as an alternative for patients who are inoperable or at high surgical risk. A series of 10 TAVR procedures showed reductions in gradient and improvements in ejection fraction. The aortic valve replacement proved feasible via the transfemoral route and was safe for high-risk patients. However, prospective studies are still needed to evaluate TAVR for lower risk patients compared to surgical replacement.
This document is a chapter from the Ontario Base Hospital Group on putting together a systematic approach to 12-lead ECG interpretation for paramedics. It outlines the objectives of using a systematic approach and simple algorithm to read ECGs quickly. The chapter then provides examples of various ECG strips with descriptions of abnormalities like ST elevation, ischemia, blocks, and prior infarcts. It concludes by emphasizing the goal of prehospital 12-lead ECG is rapid identification of STEMI patients for fast reperfusion treatments.
Where is the role for Antegrade dissection reentry?Euro CTO Club
Where is the role for Antegrade dissection reentry?
Elliot Smith, London, Great Britain
11th Experts Live CTO
The annual Euro CTO meeting
September 13th –14th, 2019 - Berlin, Germany
This document discusses techniques for treating complex tibial chronic total occlusions (CTOs). It notes that tibial CTOs are often calcified and have limited re-entry options compared to superficial femoral artery occlusions. New guidewires, support catheters, coronary CTO wires, re-entry devices, and tibial CTO-specific devices can help cross these lesions. Acute procedural success may involve angioplasty, cryoplasty, laser/atherectomy, drug-eluting balloons, or stents. However, long-term patency with angioplasty alone is poor. Retrograde and alternative access techniques can also help treat tibial CTOs previously seen as unapproach
This document discusses techniques for treating complex tibial chronic total occlusions (CTOs). It notes that tibial CTOs are often calcified and have limited re-entry options compared to superficial femoral artery occlusions. New guidewires, support catheters, re-entry devices, and CTO crossing devices can be used to cross tibial CTOs, and treatments may include angioplasty, cryoplasty, laser atherectomy, drug-eluting balloons, and stents. While plain old balloon angioplasty has shown poor long-term patency, combining techniques can achieve acute success and potentially allow wound healing.
A.Bufe - Session1 - Ischemia and Viability - How to select the right patientEuro CTO Club
1) The document discusses strategies for selecting the right patients for recanalization of a chronic total occlusion (CTO), including evaluating ischemia, viability of myocardium, and prognostic factors.
2) It reviews evidence from studies on the outcomes of CTO recanalization in different patient groups, such as those with low ejection fraction.
3) The key factors discussed for selecting patients include evaluating ischemic burden through stress testing, assessing viability through cardiac MRI, and aiming for complete revascularization of still viable myocardium.
Chapter 6 - Introduction to 12 Lead Interpretationryanhall911
This document provides a summary of a training chapter on 12-lead electrocardiogram (ECG) interpretation for paramedics. It outlines objectives of being able to recognize ST-elevation myocardial infarction (STEMI) on a 12-lead ECG. It discusses identifying important ECG features and relating them to lead locations on the heart. It emphasizes localization of STEMI rather than full interpretation. The document provides guidance on criteria for identifying STEMI and practicing recognition in various lead locations on sample ECGs.
This document summarizes the results of a study on 23 patients, mostly male and with an average age of 32.87, who underwent surgery to repair shoulder injuries. The majority of patients were right-handed and injured their shoulders participating in sports, mostly recreational. Most patients showed general shoulder laxity. Patients were followed for an average of 6.8 months after surgery and showed improvements in shoulder function based on standard assessment scores including ASES, ROWE, OXFORD, and WALCH.
Implante de válvula transcateter. Inovare - Braile via femoral.Jose Carlos Dorsa
Aortic stenosis is the most common form of cardiovascular disease after hypertension and coronary artery disease. This document discusses transcatheter aortic valve replacement (TAVR) as an alternative for patients who are inoperable or at high surgical risk. A series of 10 TAVR procedures showed reductions in gradient and improvements in ejection fraction. The aortic valve replacement proved feasible via the transfemoral route and was safe for high-risk patients. However, prospective studies are still needed to evaluate TAVR for lower risk patients compared to surgical replacement.
This document is a chapter from the Ontario Base Hospital Group on putting together a systematic approach to 12-lead ECG interpretation for paramedics. It outlines the objectives of using a systematic approach and simple algorithm to read ECGs quickly. The chapter then provides examples of various ECG strips with descriptions of abnormalities like ST elevation, ischemia, blocks, and prior infarcts. It concludes by emphasizing the goal of prehospital 12-lead ECG is rapid identification of STEMI patients for fast reperfusion treatments.
Where is the role for Antegrade dissection reentry?Euro CTO Club
Where is the role for Antegrade dissection reentry?
Elliot Smith, London, Great Britain
11th Experts Live CTO
The annual Euro CTO meeting
September 13th –14th, 2019 - Berlin, Germany
This document discusses techniques for treating complex tibial chronic total occlusions (CTOs). It notes that tibial CTOs are often calcified and have limited re-entry options compared to superficial femoral artery occlusions. New guidewires, support catheters, coronary CTO wires, re-entry devices, and tibial CTO-specific devices can help cross these lesions. Acute procedural success may involve angioplasty, cryoplasty, laser/atherectomy, drug-eluting balloons, or stents. However, long-term patency with angioplasty alone is poor. Retrograde and alternative access techniques can also help treat tibial CTOs previously seen as unapproach
This document discusses techniques for treating complex tibial chronic total occlusions (CTOs). It notes that tibial CTOs are often calcified and have limited re-entry options compared to superficial femoral artery occlusions. New guidewires, support catheters, re-entry devices, and CTO crossing devices can be used to cross tibial CTOs, and treatments may include angioplasty, cryoplasty, laser atherectomy, drug-eluting balloons, and stents. While plain old balloon angioplasty has shown poor long-term patency, combining techniques can achieve acute success and potentially allow wound healing.
This document summarizes information from a presentation on chronic total occlusions (CTOs) and multivessel disease (MVD) in acute coronary syndromes and chronic coronary syndromes. It provides data on the prevalence of CTOs in different patient populations, ranging from 10% in ACS to over 15% in elective angiography and 90% after CABG. In the SYNTAX trial, about 35.7% of patients with MVD also had a CTO. Successful recanalization of a CTO after ACS is associated with increased survival. Treatment of CTOs in patients with MVD and chronic coronary syndromes requires consideration of factors like which lesion to treat first, the ability to access lesions ante
15th Experts Live CTO: Opening Session - Emanuele BarbatoEuro CTO Club
15th Experts "Live" CTO: Auditorium Zubin Mehta - Friday 08:00
15th Experts Live CTO: Opening Session
PLENARY - OPENING SESSION
08:05
CTO in the Revascularization Guidelines
Emanuele Barbato (Rome)
___________________________________________
PLENARY - OPENING SESSION
Auditorium Zubin Mehta - Friday 8:00 - 9:00
Chairpersons:
Antonio Colombo (Milan),
Giovanni Esposito (Naples)
Discussants:
John Davies (Basildon - UK),
Marco Hautmann (Essen - D),
Aravinda Nanjundappa (Cleveland - USA)
___________________________________________
15th Experts Live CTO,
EUROCTO Club meeting in partnership with the GISE CTO meeting.
September 8th - 9th, 2023
Florence, Italy
If you want to know all the details of the event, click on the image below to download the final program, where you will be able to orient yourself on the day, time and place of a specific video recorded at 15th Experts Live CTO.
A 51-year-old male patient presented with angina and a history of smoking and dyslipidemia. He previously had a non-ST elevation myocardial infarction treated with percutaneous coronary intervention to his right coronary artery in 2017. Coronary angiography showed a chronic total occlusion in his proximal left anterior descending artery and a mid right coronary artery occlusion. Cardiac MRI showed preserved viability in the anteroseptal and anterior wall with residual ischemia and an ejection fraction of 35%. The target lesion is the proximal left anterior descending artery.
Alfredo R. Galassi - How to deal with very LVEF: the last remaining option to...Euro CTO Club
This document summarizes a presentation on CTO PCI in patients with multiple vessel disease and low left ventricular ejection fraction (LVEF). The presentation discusses:
1. The importance of assessing viability and ischemia before revascularization.
2. The need for hemodynamic support, particularly when using retrograde approaches.
3. Tips for procedural success including using the easiest CTO first and considering staged procedures.
4. The debate around complete vs. incomplete revascularization and factors to consider.
5. The importance of clinical and angiographic follow-up given the risk of restenosis in this complex patient group.
After atrial fibrillation ablation, continuous monitoring of patients is important to detect arrhythmia recurrences and assess treatment effectiveness. Implanted cardiac monitors provide highly sensitive detection of arrhythmias compared to intermittent Holter monitoring or symptom-based assessments. Continuous monitoring is needed to guide further treatment and evaluate risks of stroke and other complications related to atrial fibrillation recurrence.
Friday 1653 – karmpalotis – stent patency post cto pciEuro CTO Club
1) Stent type, crossing technique, and patient factors influence stent patency after CTO PCI. Drug-eluting stents are superior to bare metal stents in reducing restenosis and reocclusion.
2) Techniques involving extensive subintimal dissection and re-entry are associated with higher restenosis rates, especially if outflow and final TIMI flow are poor.
3) Patient factors like diabetes are also important determinants of stent patency, with diabetics having higher restenosis risks.
4) The role of routine angiographic follow-up after CTO PCI remains controversial.
Debate: Is there a difference between RDR and reverse CART? – YesEuro CTO Club
Debate: Is there a difference between RDR and reverse CART? – Yes
Hsien-Li Kao, Taipei, Taiwan
11th Experts Live CTO
The annual Euro CTO meeting
September 13th –14th, 2019 - Berlin, Germany
CTO PCI today – A summary of recent publicationsEuro CTO Club
CTO PCI today – A summary of recent publications
Carlo Di Mario, London, Great Britain
11th Experts Live CTO
The annual Euro CTO meeting
September 13th –14th, 2019 - Berlin, Germany
This document summarizes postmarketing studies comparing the Russian-made Calypso drug-eluting stent to analogous foreign stents. It describes two ongoing comparative registry studies - E-Calypso and Patriot - that are evaluating the safety and efficacy of the Calypso stent versus competitors like the Resolute Integrity and Xience Prime stents. The document outlines the study designs, endpoints, inclusion/exclusion criteria and administrative details of the comparative studies which are taking place in Russia through 2016. It also provides technical specifications and performance data indicating the Calypso stent is competitive with leading foreign stents while offering significant cost savings.
Tim Schäufele - SuccessfultransradialretrogradeCTO revascularisation via an e...Euro CTO Club
A 76-year-old female with recurrent angina underwent a transradial retrograde CTO revascularization via an epicardial collateral using a single 6F guide catheter. Baseline angiography and cMRI showed 3-vessel disease with functional stenosis in the RCA and RCX territories. An antegrade wire escalation approach was unsuccessful, so a retrograde approach via an epicardial collateral was used. The CTO was crossed retrogradely and externalized antegradely using the single 6F guide. Final angiography after stent placement in the RCA, LAD and RCX showed good results and the patient's angina was resolved at 9-month follow-up.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
U.F. is an 81-year-old male who presented with angina and has a history of hypertension, dyslipidemia, COPD, prior right pneumonectomy for lung cancer, and peripheral arterial disease. Angiography showed a CTO of the proximal LAD, and PET imaging found anteroapical ischemia. The target lesion is a proximal LAD CTO.
1) The document discusses carotid artery stenting (CAS) and carotid endarterectomy (CEA) for treating carotid artery disease. It reviews data from clinical trials comparing the two procedures.
2) Operator experience is an important factor for CAS outcomes, with over 100 cases associated with lower risk. New technologies like mesh-covered stents may further reduce risks of CAS.
3) Future studies like CREST-2 aim to provide more data on CAS and CEA in asymptomatic patients to help guide treatment decisions. Both procedures can effectively treat carotid artery disease when performed by experienced operators.
15th Experts Live CTO - Carlo Di Mario: ConclusionsEuro CTO Club
PLENARY SESSION
Wrap up of live cases, awards to the winners of the best abstracts and case competitions and take home messages
Auditorium Zubin Mehta - Saturday 16:00 - 17:00
Speakers:
Daniela Benedetto (Rome),
Francesco Burzotta (Rome),
Carlo Di Mario (Florence),
Roberto Garbo (Turin),
Rocco Stio (Rome)
Challengers:
Stelios Pyxaras (Furth - D),
Sudhir Rathore (London - UK)
Discussants:
Shunsuke Matsuno (Tokyo - J),
Alexander Nap (Amsterdam - NL),
Masahisa Yamane (Tokyo - J)
___________________________________________
15th Experts Live CTO,
EUROCTO Club meeting in partnership with the GISE CTO meeting.
September 8th - 9th, 2023
Florence, Italy
Francesco Burzotta: Wrap up Gemelli CasesEuro CTO Club
PLENARY SESSION
Wrap up of live cases, awards to the winners of the best abstracts and case competitions and take home messages
Auditorium Zubin Mehta - Saturday 16:00 - 17:00
Speakers:
Daniela Benedetto (Rome),
Francesco Burzotta (Rome),
Carlo Di Mario (Florence),
Roberto Garbo (Turin),
Rocco Stio (Rome)
Challengers:
Stelios Pyxaras (Furth - D),
Sudhir Rathore (London - UK)
Discussants:
Shunsuke Matsuno (Tokyo - J),
Alexander Nap (Amsterdam - NL),
Masahisa Yamane (Tokyo - J)
___________________________________________
15th Experts Live CTO,
EUROCTO Club meeting in partnership with the GISE CTO meeting.
September 8th - 9th, 2023
Florence, Italy
This document summarizes information from a presentation on chronic total occlusions (CTOs) and multivessel disease (MVD) in acute coronary syndromes and chronic coronary syndromes. It provides data on the prevalence of CTOs in different patient populations, ranging from 10% in ACS to over 15% in elective angiography and 90% after CABG. In the SYNTAX trial, about 35.7% of patients with MVD also had a CTO. Successful recanalization of a CTO after ACS is associated with increased survival. Treatment of CTOs in patients with MVD and chronic coronary syndromes requires consideration of factors like which lesion to treat first, the ability to access lesions ante
15th Experts Live CTO: Opening Session - Emanuele BarbatoEuro CTO Club
15th Experts "Live" CTO: Auditorium Zubin Mehta - Friday 08:00
15th Experts Live CTO: Opening Session
PLENARY - OPENING SESSION
08:05
CTO in the Revascularization Guidelines
Emanuele Barbato (Rome)
___________________________________________
PLENARY - OPENING SESSION
Auditorium Zubin Mehta - Friday 8:00 - 9:00
Chairpersons:
Antonio Colombo (Milan),
Giovanni Esposito (Naples)
Discussants:
John Davies (Basildon - UK),
Marco Hautmann (Essen - D),
Aravinda Nanjundappa (Cleveland - USA)
___________________________________________
15th Experts Live CTO,
EUROCTO Club meeting in partnership with the GISE CTO meeting.
September 8th - 9th, 2023
Florence, Italy
If you want to know all the details of the event, click on the image below to download the final program, where you will be able to orient yourself on the day, time and place of a specific video recorded at 15th Experts Live CTO.
A 51-year-old male patient presented with angina and a history of smoking and dyslipidemia. He previously had a non-ST elevation myocardial infarction treated with percutaneous coronary intervention to his right coronary artery in 2017. Coronary angiography showed a chronic total occlusion in his proximal left anterior descending artery and a mid right coronary artery occlusion. Cardiac MRI showed preserved viability in the anteroseptal and anterior wall with residual ischemia and an ejection fraction of 35%. The target lesion is the proximal left anterior descending artery.
Alfredo R. Galassi - How to deal with very LVEF: the last remaining option to...Euro CTO Club
This document summarizes a presentation on CTO PCI in patients with multiple vessel disease and low left ventricular ejection fraction (LVEF). The presentation discusses:
1. The importance of assessing viability and ischemia before revascularization.
2. The need for hemodynamic support, particularly when using retrograde approaches.
3. Tips for procedural success including using the easiest CTO first and considering staged procedures.
4. The debate around complete vs. incomplete revascularization and factors to consider.
5. The importance of clinical and angiographic follow-up given the risk of restenosis in this complex patient group.
After atrial fibrillation ablation, continuous monitoring of patients is important to detect arrhythmia recurrences and assess treatment effectiveness. Implanted cardiac monitors provide highly sensitive detection of arrhythmias compared to intermittent Holter monitoring or symptom-based assessments. Continuous monitoring is needed to guide further treatment and evaluate risks of stroke and other complications related to atrial fibrillation recurrence.
Friday 1653 – karmpalotis – stent patency post cto pciEuro CTO Club
1) Stent type, crossing technique, and patient factors influence stent patency after CTO PCI. Drug-eluting stents are superior to bare metal stents in reducing restenosis and reocclusion.
2) Techniques involving extensive subintimal dissection and re-entry are associated with higher restenosis rates, especially if outflow and final TIMI flow are poor.
3) Patient factors like diabetes are also important determinants of stent patency, with diabetics having higher restenosis risks.
4) The role of routine angiographic follow-up after CTO PCI remains controversial.
Debate: Is there a difference between RDR and reverse CART? – YesEuro CTO Club
Debate: Is there a difference between RDR and reverse CART? – Yes
Hsien-Li Kao, Taipei, Taiwan
11th Experts Live CTO
The annual Euro CTO meeting
September 13th –14th, 2019 - Berlin, Germany
CTO PCI today – A summary of recent publicationsEuro CTO Club
CTO PCI today – A summary of recent publications
Carlo Di Mario, London, Great Britain
11th Experts Live CTO
The annual Euro CTO meeting
September 13th –14th, 2019 - Berlin, Germany
This document summarizes postmarketing studies comparing the Russian-made Calypso drug-eluting stent to analogous foreign stents. It describes two ongoing comparative registry studies - E-Calypso and Patriot - that are evaluating the safety and efficacy of the Calypso stent versus competitors like the Resolute Integrity and Xience Prime stents. The document outlines the study designs, endpoints, inclusion/exclusion criteria and administrative details of the comparative studies which are taking place in Russia through 2016. It also provides technical specifications and performance data indicating the Calypso stent is competitive with leading foreign stents while offering significant cost savings.
Tim Schäufele - SuccessfultransradialretrogradeCTO revascularisation via an e...Euro CTO Club
A 76-year-old female with recurrent angina underwent a transradial retrograde CTO revascularization via an epicardial collateral using a single 6F guide catheter. Baseline angiography and cMRI showed 3-vessel disease with functional stenosis in the RCA and RCX territories. An antegrade wire escalation approach was unsuccessful, so a retrograde approach via an epicardial collateral was used. The CTO was crossed retrogradely and externalized antegradely using the single 6F guide. Final angiography after stent placement in the RCA, LAD and RCX showed good results and the patient's angina was resolved at 9-month follow-up.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
U.F. is an 81-year-old male who presented with angina and has a history of hypertension, dyslipidemia, COPD, prior right pneumonectomy for lung cancer, and peripheral arterial disease. Angiography showed a CTO of the proximal LAD, and PET imaging found anteroapical ischemia. The target lesion is a proximal LAD CTO.
1) The document discusses carotid artery stenting (CAS) and carotid endarterectomy (CEA) for treating carotid artery disease. It reviews data from clinical trials comparing the two procedures.
2) Operator experience is an important factor for CAS outcomes, with over 100 cases associated with lower risk. New technologies like mesh-covered stents may further reduce risks of CAS.
3) Future studies like CREST-2 aim to provide more data on CAS and CEA in asymptomatic patients to help guide treatment decisions. Both procedures can effectively treat carotid artery disease when performed by experienced operators.
15th Experts Live CTO - Carlo Di Mario: ConclusionsEuro CTO Club
PLENARY SESSION
Wrap up of live cases, awards to the winners of the best abstracts and case competitions and take home messages
Auditorium Zubin Mehta - Saturday 16:00 - 17:00
Speakers:
Daniela Benedetto (Rome),
Francesco Burzotta (Rome),
Carlo Di Mario (Florence),
Roberto Garbo (Turin),
Rocco Stio (Rome)
Challengers:
Stelios Pyxaras (Furth - D),
Sudhir Rathore (London - UK)
Discussants:
Shunsuke Matsuno (Tokyo - J),
Alexander Nap (Amsterdam - NL),
Masahisa Yamane (Tokyo - J)
___________________________________________
15th Experts Live CTO,
EUROCTO Club meeting in partnership with the GISE CTO meeting.
September 8th - 9th, 2023
Florence, Italy
Francesco Burzotta: Wrap up Gemelli CasesEuro CTO Club
PLENARY SESSION
Wrap up of live cases, awards to the winners of the best abstracts and case competitions and take home messages
Auditorium Zubin Mehta - Saturday 16:00 - 17:00
Speakers:
Daniela Benedetto (Rome),
Francesco Burzotta (Rome),
Carlo Di Mario (Florence),
Roberto Garbo (Turin),
Rocco Stio (Rome)
Challengers:
Stelios Pyxaras (Furth - D),
Sudhir Rathore (London - UK)
Discussants:
Shunsuke Matsuno (Tokyo - J),
Alexander Nap (Amsterdam - NL),
Masahisa Yamane (Tokyo - J)
___________________________________________
15th Experts Live CTO,
EUROCTO Club meeting in partnership with the GISE CTO meeting.
September 8th - 9th, 2023
Florence, Italy
Jonathan Hill: Role of mechanica support in CTO recanalizationEuro CTO Club
10:42
Role of mechanica support in CTO recanalization
Jonathan Hill (London - UK)
___________________________________________
PARALLEL SESSION
Challenges And Opportunities In Cto Recanalization
Auditorium Zubin Mehta - Saturday 10:00 - 11:10
Chairperson:
Jonathan Hill (London - UK)
Discussants:
Lesnek Bryniarski (Krakow - PL),
Ugo Fabrizio (Vercelli),
Paul Knaapen (Amsterdam - NL),
Eugenio La Scala (Ollioiouls - F)
___________________________________________
15th Experts Live CTO,
EUROCTO Club meeting in partnership with the GISE CTO meeting.
September 8th - 9th, 2023
Florence, Italy
Gregor Leibundgut: Role of DEB in CTO-PCIEuro CTO Club
10:35 Role of DEB in CTO-PCI
Gregor Leibundgut (Basel - CH)
___________________________________________
PARALLEL SESSION
Challenges And Opportunities In Cto Recanalization
Auditorium Zubin Mehta - Saturday 10:00 - 11:10
Chairperson:
Jonathan Hill (London - UK)
Discussants:
Lesnek Bryniarski (Krakow - PL),
Ugo Fabrizio (Vercelli),
Paul Knaapen (Amsterdam - NL),
Eugenio La Scala (Ollioiouls - F)
___________________________________________
15th Experts Live CTO,
EUROCTO Club meeting in partnership with the GISE CTO meeting.
September 8th - 9th, 2023
Florence, Italy
Kambis Mashayekhi: EuroCTO Consensus on treatment of Calcified CTO lesion Eur...Euro CTO Club
AUDITORIUM ZUBIN MEHTA
08/09/2023 04:30 - 05:20
PLENARY SESSION - INTERVENTIONAL CTO & CHIP RESEARCH Best CTO Publications 2022-23 (selected by the Editors of the Cardiology Interventional journals)
Emmanouil S. Brilakis - CTO PCI Outcome associated with poor quality of the d...Euro CTO Club
16:53
CTO PCI Outcome associated with poor quality of the distal target vessel
Emmanouil Brilakis (Minneapolis - USA)
_____________________________________________
PARALLEL SESSION
Interventional CTO & Chip Research
Best CTO Publications 2022-23 (selected by the Editors of the Cardiology Interventional journals)
Auditorium Zubin Mehta - Friday 16:30 - 17:16
Chairpersons:
Davide Capodanno (Catania),
Carlo Di Mario (Florence),
Giuseppe Tarantini (Padua)
Panelist:
Roberto Diletti (Rotterdam - NL),
Giovanni Esposito (Naples),
Paul Knaapen (Amsterdam - NL),
Maksymilian Opolski (Warsaw - PL)
___________________________________________
15th Experts Live CTO,
EUROCTO Club meeting in partnership with the GISE CTO meeting.
September 8th - 9th, 2023
Florence, Italy
Mario Iannaccone - 2 EuroCTO Consensus on Guide Catheter Extensions JACC Card...Euro CTO Club
16:33
EuroCTO Consensus on Guide Catheter Extensions JACC Cardiovasc Interventions
Mario Iannaccone (Turin)
_____________________________________________
PARALLEL SESSION
Interventional CTO & Chip Research
Best CTO Publications 2022-23 (selected by the Editors of the Cardiology Interventional journals)
Auditorium Zubin Mehta - Friday 16:30 - 17:16
Chairpersons:
Davide Capodanno (Catania),
Carlo Di Mario (Florence),
Giuseppe Tarantini (Padua)
Panelist:
Roberto Diletti (Rotterdam - NL),
Giovanni Esposito (Naples),
Paul Knaapen (Amsterdam - NL),
Maksymilian Opolski (Warsaw - PL)
___________________________________________
15th Experts Live CTO,
EUROCTO Club meeting in partnership with the GISE CTO meeting.
September 8th - 9th, 2023
Florence, Italy
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
ACS and CTO – how to manage
1. ACS and CTO – how to manage
E u r o C T O - C l u b , „ T h e E x p e r t s L i v e “ , B e r n w a r d L a u e r , B e r l i n , S e p t e m b e r 1 5 t h 2 0 1 7
2. ACS AND CTO –HOW OFTEN
2
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Year ACS Region Study population MVD CTO
Ariza-Solé 2013 STEMI Spain 1176 125 (10,6%)
Choi 2016 STEMI Korea 4748 324 (6,8%)
Hoebers 2013 NSTEMI Netherlands 5018 1819 (36,3%) 666 (13,3%)
Lesiak 2017 STEMI Poland 836 437 (52,3%) 146 (17,5%)
Miziguchi 2013 AMI Japan 417 35 (8,0%)
Tajstra 2012 STEMI Poland 1658 666 (40,2%) 204 (12,3%)
Valenti 2012 AMI Italy 1911 169 (8,8%)
Wanatanabe 2017 STEMI Korea 5429 2045 (37,7%) 383 (7,1%)
Total 21193 2052 (9,7%)
Ariza-Solé A et al. Rev Esp Cardiol 2014; 67(5): 359-366; Choi IJ et al. Am J Cardiol 2016;117:1039-1046; Hoebers LPC et al. Eur J Heart Fail 2013 15(4) 425-432;
Lesiak M et al. Cardiol J 2017 24(2) 117-124; Mizuguchi Y et al. Int J Cardiol 2014 176(3) 1139-1141; Tajstra M et al. Am J Cardiol 2012 109(2) 208-213;
Valenti Ret al. Am J Cardiol 2014 114(12) 1794-1800; Wanatanabe H et al. Eurointervention 2017 12(15) e1874-e1882
3. ACS AND CTO –PROGNOSIS
3
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
HORIZONS-AMI
Claessen et al.; Eur Heart J. 2012 33(6) 768-775
4. ACS AND CTO –PROGNOSIS
4
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
HORIZONS-AMI
Claessen et al.; Eur Heart J. 2012 33(6) 768-775
5. ACS AND CTO –PROGNOSIS
5
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Single vs. Multiple CTOs
Hoebers LP et al. Eur J Heart Fail. 2013 15(4) 425-432
6. ACS AND CTO –PROGNOSIS
6
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Survival curve of patients without cardiogenic shock on admission after
primary PCI according to the presence of CTO. Legend: survival in patients
with STEMI after primary PCI for patients with no CTO, 1 CTO, or N1CTO.
Survival curve of patients with cardiogenic shock on admission after
primary PCI according to the presence of CTO. Legend: survival in patients
with STEMI primary PCI for patients with no CTO, 1 CTO, or N1 CTO.
Bataille Y et al; Am Heart J. 2012 164(4) 509-515
in cardiogenic shock
7. ACS AND CTO –PROGNOSIS
7
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Hoebers LP et al. Eur J Heart Fail. 2013 15(4) 425-432
in cardiogenic shock
Total population Cardiogenic shockNo cardiogenic shock
8. ACS AND CTO –PROGNOSIS
8
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
IRA localisation
Hoebers LP et al. Eur J Heart Fail. 2013 15(4) 425-432
9. ACS AND CTO –PROGNOSIS
9
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
CTO localisation
Hoebers LP et al. Eur J Heart Fail. 2013 15(4) 425-432
10. ACS AND CTO –PROGNOSIS
10
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
CTO collateral quality
Fujii T et al Int J Cardiol. 2017 (230) 346-352
11. ACS AND CTO –PROGNOSIS
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
CTO collateral quality
Elias JA et al JACC Cardiovascular Interventions 2017 10(9) 906-914
12. ACS AND CTO –PROGNOSIS
12
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
CTO collateral donor
Fujii T et al. Int J Cardiol. 2016 (218) 158-163
13. ACS AND CTO –PROGNOSIS
13
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Summary
Higher mortality with
a CTO vs. no CTO
more than one CTO
in cardiogenic shock
LAD as IRA
poor collaterals
Collaterals from IRA
14. ACS AND CTO –REVASCULARISATION
14
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Henriques JP et al. J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632
RCT: EXPLORE trial
15. ACS AND CTO –REVASCULARISATION
15
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
RCT: EXPLORE trial
Henriques JP et al. J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632
16. ACS AND CTO –REVASCULARISATION
16
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Choi IJ et al. Am J Cardiol. 2016 117(7) 1039-1046
Prognosis with/without successful recanalisation of CTO
17. ACS AND CTO –REVASCULARISATION
17
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Shi G et al.ScientificWorldJournal. 2014 756080
Prognosis with/without successful recanalisation of CTO
18. ACS AND CTO –REVASCULARISATION
18
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Valenti R et al. Am J Cardiol. 2014 114(12) 1794-1800
Prognosis with/without successful recanalisation of CTO
19. ACS AND CTO –REVASCULARISATION
19
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Prognosis with/without successful recanalisation of CTO
Yang ZK et al. Int J Cardiol. 2013 165(1) 76-79
20. ACS AND CTO –REVASCULARISATION WHEN
20
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Optimal time point of revascularisation of the CTO
in stable patients: ?
in cardiogenic shock: ?
21. ACS AND CTO –REVASCULARISATION WHEN
21
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Optimal time point of revascularisation of the CTO
in stable patients: ?
most probably staged procedures
in cardiogenic shock: ?
22. ACS AND CTO –REVASCULARISATION WHEN
22
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Optimal time point of revascularisation of the CTO
in stable patients: ?
most probably staged procedures
in cardiogenic shock: ?
probably (short (?)) acute attempt ???
23. ACS AND CTO –REVASCULARISATION WHEN
23
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Optimal time point of revascularisation of the CTO
in stable patients: ?
most probably staged procedures
in cardiogenic shock: ?
probably (short (?)) acute attempt ???
Room for discussion and trials
24. ACS AND CTO –HOW OFTEN
24
EuroCTO-Club, "The Experts Live", Berlin, September 2017, Bernward Lauer
Conclusion
In patients with an acute coronary syndrome
• the presence of a CTO is associated with a higher mortality
• revascularisation of the CTO seems to improve prognosis
• optimal timing of CTO-revascularisation is unknown
• in stable patient: staged procedures (?)
• in cardiogenic shock: immediate complete revascularisation (?)